Health Care · Industrial Organic Chemicals

SXT SENSIENT TECHNOLOGIES CORP SEC Filings & Insider Trading Activity 2026

company
CIK 310142111 filings
Russell 2000

SXT at a glance

SENSIENT TECHNOLOGIES CORP (SXT, SEC CIK 310142) filed its latest 10-K annual report on February 13, 2026, a 10-Q quarterly report on October 30, 2026, an 8-K current report on November 4, 2026 and Form 4 insider filings as recently as October 1, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended December 31, 2025 (FY2025), SENSIENT TECHNOLOGIES CORP (SXT) reported revenue of $1.6 billion (up 3.5% from FY2024) and net income of $134.5 million. Diluted EPS was $3.16.
  • As of September 30, 2026, 32 institutional investment managers tracked by SignalX reported holding SENSIENT TECHNOLOGIES CORP (SXT) shares worth $2.5 billion in 13F-HR filings.
  • The most recent insider open-market sale reported on Form 4 was by Ferruzzi Mario on August 5, 2026 of 1,200 shares at $129.48 per share.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2025
$1.6B
+3.5% vs prior year
Insiders · 90 days
0 buys · 0 sells
No open-market trades
13F holders
32 funds
$2.5B · −1 vs prior quarter
Latest 8-K
Nov 4, 2026
Item 5.02

AI 10-K Annual Report Analysis

Latest 10-K, fiscal year ended Dec 31, 2025

Full analysis →

Business Overview

  • Core business: global manufacturer and marketer of colors, flavors, and specialty ingredients for food, beverage, pharmaceutical, nutraceutical, and personal care industries
  • New emphasis on converting $100 million synthetic food color revenue in North America to natural colors due to legislative and market demand shifts
  • Strategic repositioning with accelerated investment in natural color production capacity, product portfolio expansion, and resilient supply chains
  • Employee count steady at 4,070 worldwide as of December 31, 2025, with 496 in R&D and 45% U.S.-based workforce
  • 2025 acquisition of Biolie SAS in France for $4.9 million to enhance natural color extraction capabilities within the Color segment

Risk Factors

  • Cybersecurity risk oversight by full Board with biannual CIO reports on threat landscape and incident response
  • Executive steering committee including CEO and CFO focused on cybersecurity risk management and strategy
  • Key information security leaders total 90+ years experience with CISSP certification managing incident prevention and remediation

AI summary of the SXT 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Sep 30, 2026

Risk Factors

  • No material changes to previously disclosed risk factors in the 2025 Form 10-K
  • Continued exposure to the significant risks identified in the 2025 annual filing

Management Discussion & Analysis

  • Revenue $455.8M, up 10.6% from $412.1M, driven by higher volumes and selling prices
  • Operating margin 15.9% vs 14.0%; gross margin 36.2% vs 34.3%
  • Best segment Color: revenue $210.3M vs $178.2M, operating margin 21.9% vs 21.2%
  • Operating cash flow $75.3M vs $83.3M; capital expenditures $105.8M vs $57.8M
  • Outlook: higher tariff and input costs, expected pricing offsets, increased short-term indebtedness for conversion investments

AI summary of the SXT 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Nov 4, 2026Full analysis →

Item 5.02: Departure/Appointment of Directors or Principal Officers

  • Board expanded from nine to ten members, adding two directors effective December 2, 2026
  • Ernest Chan and Philip Yu fill one vacancy from a director’s death and one newly created seat
Filed Oct 30, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • October 30, 2026 press release reports Sensient’s third-quarter results for quarter ended September 30, 2026
  • Exhibit 99.1 contains the company’s operating results and financial-condition details for investor review

Item 7.01: Regulation FD Disclosure

  • Updated investor presentation for quarter ended September 30, 2026, posted October 30, 2026
  • Exhibit 99.2 contains the presentation, providing additional investor-focused operating and financial context

Item EX-99.1: Item EX-99.1

  • Q3 revenue $455.8M, up 10.6%, with Color strongest at 18.1% growth on volume gains
  • Operating income $72.4M, up 25.5%, aided by no Portfolio Optimization Plan costs versus $3.3M last year

Item EX-99.2: Item EX-99.2

  • Q3 revenue rose 10.2% to $455.8 million, supported by volume growth, pricing and favorable operating leverage
  • GAAP operating margin expanded to 15.9% from 14.0%, while diluted EPS increased to $1.13 from $0.87
Filed Sep 2, 2026Full analysis →

Item 1.01: Entry into a Material Definitive Agreement

  • Receivables securitization facility increased from $105 million to $115 million
  • PNC added as purchaser and administrative agent alongside Wells Fargo

Item 2.03: Creation of a Direct Financial Obligation

  • Item 2.03 links to Item 1.01, indicating a material agreement created a direct financial obligation
  • Investors should review Item 1.01 for the obligation’s amount, terms, maturity and business purpose

AI summaries of SXT 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for SXT

Don't miss the next SXT filing

  • Alerts as it files. A push when SXT files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut SXT, by share count.
  • Ask anything. An AI agent that reads every SXT filing and answers with sources.

SXT alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
Carleone JosephASep 30, 2026-
Ferruzzi MarioASep 30, 2026-
Ferruzzi MarioSellAug 5, 2026$129.48
Ferruzzi MarioAJun 30, 2026-
Carleone JosephAJun 30, 2026-
Hoang ThierrySellMay 18, 2026$115.19
Hoang ThierrySellMay 4, 2026$114.15
Morris Steven BSellApr 30, 2026$114.58

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2023FY2024FY2025
Profitability
Revenue-$1.6B$1.6B
Operating Income-$191.6M$207.1M
Net Income$93.4M$124.7M$134.5M
Op. Margin-12.3%12.8%
Net Margin-8.0%8.3%
Balance Sheet
Total Assets$2.0B$2.0B$2.2B
Equity-$1.1B$1.2B
ROE-11.8%11.3%
Per Share
EPS$2.21$2.94$3.16
Cash Flow
Operating CF-$157.2M$127.8M
CapEx$87.9M$59.2M$89.4M

Source: XBRL data in SENSIENT TECHNOLOGIES CORP (SXT)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q3 2026

Aggregate SXT share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
SXT shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q3 202632$2.54B
Q2 202633$2.43B
Q1 202632$1.64B
Q4 202531$1.82B
Q3 202531$1.83B
Q2 202532$1.88B
Q1 202528$819.9M
Q4 202423$723.9M
Position changes: Q2 2026 → Q3 2026
Top Buyers
Top Sellers
New Positions
Closed Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 242 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

SXT filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
8-KNov 4, 2026Analysis-
10-QOct 30, 2026Analysis
8-KOct 30, 2026Analysis-
4Oct 1, 2026--
4Oct 1, 2026--
8-KSep 2, 2026Analysis-
4Aug 6, 2026--
10-QAug 4, 2026Analysis
8-KJul 24, 2026Analysis-
4Jul 1, 2026--
4Jul 1, 2026--
8-KJun 23, 2026Analysis-
4May 20, 2026-
4May 6, 2026-
10-QMay 5, 2026Analysis
4May 1, 2026--
4May 1, 2026--
SC 13GApr 30, 2026-
SC 13GApr 29, 2026-
8-KApr 28, 2026Analysis-
4Apr 27, 2026--
4Apr 27, 2026--
4Apr 27, 2026--
4Apr 27, 2026--
4Apr 27, 2026--

Related Health Care companies

All Health Care →

SXT SEC filings: frequently asked questions

Which institutions hold SXT stock?

As of September 30, 2026, the largest SENSIENT TECHNOLOGIES CORP (SXT) holders among the 13F filers tracked by SignalX were BlackRock ($850.1 million), Vanguard Portfolio Management LLC ($363.3 million), Vanguard Capital Management LLC ($250.5 million), State Street Corp ($223.3 million), Dimensional Fund Advisors ($133.8 million). 13F-HR reports are filed up to 45 days after each quarter ends.

What was SXT's revenue in fiscal year 2025?

For the fiscal year ended December 31, 2025 (FY2025), SENSIENT TECHNOLOGIES CORP (SXT) reported revenue of $1.6 billion (up 3.5% from FY2024) and net income of $134.5 million. Diluted EPS was $3.16. The figures come from the XBRL data in the 10-K.

What are the main risks in SXT's latest 10-K?

In the 10-K filed February 13, 2026, SENSIENT TECHNOLOGIES CORP (SXT) flagged: Cybersecurity risk oversight by full Board with biannual CIO reports on threat landscape and incident response. Executive steering committee including CEO and CFO focused on cybersecurity risk management and strategy. (AI summary of the Risk Factors section.)

What did SXT report in its latest 8-K?

SENSIENT TECHNOLOGIES CORP (SXT) filed an 8-K on November 4, 2026 reporting Item 5.02 (Departure/Appointment of Directors or Principal Officers). Board expanded from nine to ten members, adding two directors effective December 2, 2026.

What are the latest SXT SEC filings?

SENSIENT TECHNOLOGIES CORP (SXT) filed its latest 10-K annual report on February 13, 2026, a 10-Q quarterly report on October 30, 2026, an 8-K current report on November 4, 2026 and a Form 4 insider filing on October 1, 2026.

What is SXT's SEC CIK number?

SENSIENT TECHNOLOGIES CORP (SXT)'s SEC Central Index Key (CIK) is 310142. EDGAR lists every SXT filing under that number.

Ask anything about SXT

The research agent reads SXT's filings, financials, insider trades and 13F holders, then answers with sources.